New Enterprise Associates

News

Trevena grabs $35M to fund trials of heart-failure drug

Trevena Inc. has landed a sizable $35 million Series B round that it hopes will push its lead heart-failure drug through Phase 2 clinical trials. The funding was led by venture heavyweights and existing investors Polaris Venture Partners and New Enterprise Associates. Other previous investors — Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company […]

presented by
News

Apnex Medical names former BSX and J&J executive as its new CEO

Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea (OSA), has named Charles McKhann as its new CEO. McKhann, who previously served as a global vice president of marketing for Boston Scientific Corp.’s (NYSE: BSX) cardiac rhythm management division, replaces founder and executive director Robert Atkinson. While at Johnson & […]

News

Josh Makower for president

“Are you ready to listen about the demise of our industry?” one med tech executive asked another at today’s LifeScience Alley luncheon. “Yes, I’m morbidly interested,” the other joked back. Such gallows humor pervades the medical device industry these days. And not without good reason. For months, I’ve heard panelist after panelist, expert after expert, […]

presented by